Cambridge, MA, July 17, 2017 – Astrocyte Pharmaceuticals Inc. announced today that it has completed its seed financing round raising over $2.4M.  The company is developing novel small molecule drugs...

Cambridge, MA, March 24, 2017 – Astrocyte Pharmaceuticals Inc., a CNS therapeutics startup, announced today that it has raised approximately $1.36M in a seed financing round.  The company is developing...

Cambridge, MA, October 19, 2015 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that David W. Wright, M.D., has joined the company’s Scientific Advisory Board....

Cambridge, MA, September 21, 2015 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that it has been awarded a Phase 1 Small Business Technology Transfer (STTR)...

Cambridge, MA, July 16, 2015 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that Susan S. Margulies, Ph.D. has joined the company’s Scientific Advisory Board....

Cambridge, Mass. (May 7, 2015) – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, today announced it has entered into an exclusive worldwide licensing agreement with The University...

Cambridge, Mass., May 1, 2015 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that Theodore E. Liston, Ph.D. has joined the company as Vice President of Pharmacokinetics...

The 5th Annual Traumatic Brain Injury (TBI) Conference is being held on April 15 and 16, 2015 in Washington DC. The conference will feature the latest research findings from many leading TBI researchers...

Cambridge, Mass., December 1, 2014 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, today announced that Jeffrey L. Ives, Ph.D. has joined the company’s Board of Directors....